Skip to main content
logo
Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea flag South Korea · Delayed Price · Currency is KRW
59,200
-5,800 (-8.92%)
Sep 1, 2026, 3:30 PM KST

Orum Therapeutics Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
40.5523.5620,906135,41875.92
Revenue Growth
-99.81%-99.89%-84.56%178270.49%-
Gross Profit
40.2323.3120,904135,41875.09
Operating Income
-65,622-51,759-8,33595,607-43,648
Net Income
18,511-41,969-5,74068,217-63,319
Earnings Per Share
869.48-2016.61-424.005646.14-13764.93
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
251,906132,602118,799126,65812,085
Total Debt
96,19825,49828,33025,8792,589
Net Cash (Debt)
155,709107,10390,469100,7799,496
Net Cash Growth
25.32%18.39%-10.23%961.28%-
Net Cash Per Share
7313.735146.286682.586693.642064.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-52,158-35,989-11,28294,244-41,092
Capital Expenditures
-582.18-696.27-1,264-1,126-796.13
Free Cash Flow
-52,740-36,685-12,54593,117-41,888
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
99.21%98.91%99.99%100.00%98.91%
Operating Margin
-161817.86%-219651.47%-39.87%70.60%-57492.65%
Pretax Margin
40263.36%-187369.48%-25.42%50.14%-83105.78%
Profit Margin
45646.42%-178105.43%-27.46%50.38%-83402.60%
FCF Margin
-130052.37%-155680.70%-60.01%68.76%-55173.99%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
31706.51108125.08---